Smoking giant BAT reports more profit from non-tobacco products like vapes

The London-listed company said it has about 40% market share in key countries such as the US and the UK for vaping.

Alex Daniel
Wednesday 11 December 2024 09:17 GMT
BAT will give shareholders an update on its trading performance on Tuesday (Alamy/PA)
BAT will give shareholders an update on its trading performance on Tuesday (Alamy/PA)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

British American Tobacco (BAT) has said it is on track to make more money from selling vapes in the second half of the financial year than the first.

The smoking giant said in a trading update that it had about 40% vaping market share across key markets like the US and the UK with its Vuse products.

However, it added that global tobacco industry volumes are expected to be down 2% year-on-year as more people turn away from smoking traditional cigarettes.

Chief executive Tadeu Marroco said the company is making “further progress increasing profitability” across “new category” products.

BAT since the start of the year" data-source="">

Analysts have projected total sales for the year to be down slightly on 2023, at £26.3 billion, while BAT’s Vype, Glo and Vuse vaping products should see sales rise about 9% to £3.6 billion.

Revenue and adjusted profit for the year was in line with previous guidance for low single-figure organic growth, the company said.

Mr Marroco said the company’s move towards vapes and oral products was making “progress”.

The strategy will see BAT become a “predominantly” smokeless business by 2035, and has seen shares rise 30% in the last year.

However, BAT also said it had seen a 9% fall in US industry volumes since the start of the year.

It said “continued macro-economic pressures and the impact of illicit single-use vapour products” were behind the fall.

The trading update comes amid a ramp-up in anti-smoking regulation and taxes from governments around the world on public health grounds.

Smokers and vapers in the UK will pay more after Chancellor Rachel Reeves announced a new vaping tax and an increase in tobacco duty to “maintain the incentive to give up smoking”.

The flat rate duty on all vaping liquid will come into effect from October 2026.

Meanwhile, the Tobacco and Vapes Bill has been introduced in Parliament, which would prevent anyone born after January 1 2009 from legally smoking by gradually raising the age at which tobacco can be bought.

But the Government has reversed potential plans to make it illegal to smoke in pub beer gardens.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in